Masoud H Manjili

Masoud H Manjili

UNVERIFIED PROFILE

Are you Masoud H Manjili?   Register this Author

Register author
Masoud H Manjili

Masoud H Manjili

Publications by authors named "Masoud H Manjili"

Are you Masoud H Manjili?   Register this Author

96Publications

1611Reads

20Profile Views

The microbiome and breast cancer: a review.

Breast Cancer Res Treat 2019 Dec 27;178(3):493-496. Epub 2019 Aug 27.

Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, 21224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05407-5DOI Listing
December 2019

A Theoretical Basis for the Efficacy of Cancer Immunotherapy and Immunogenic Tumor Dormancy: The Adaptation Model of Immunity.

Authors:
Masoud H Manjili

Adv Cancer Res 2018 10;137:17-36. Epub 2018 Jan 10.

VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, United States; VCU Massey Cancer Center, Virginia Commonwealth University, School of Medicine, Richmond, VA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.acr.2017.11.005DOI Listing
October 2019

Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer.

Cancers (Basel) 2019 Aug 19;11(8). Epub 2019 Aug 19.

Faculty of Medicine, Cardinal Stefan Wyszyński University in Warsaw, 01-938 Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11081207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721805PMC
August 2019

Gr1 CD11b MHCII myeloid cells boost T cell anti-tumor efficacy.

J Leukoc Biol 2018 12 9;104(6):1215-1228. Epub 2018 Jul 9.

Department of Microbiology & Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/JLB.5A0717-276RRDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258302PMC
December 2018

IFN-γ orchestrates tumor elimination, tumor dormancy, tumor escape, and progression.

J Leukoc Biol 2018 Feb 22. Epub 2018 Feb 22.

Department of Microbiology & Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/JLB.5MIR0917-351RDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157004PMC
February 2018

Human mast cells present antigen to autologous CD4 T cells.

J Allergy Clin Immunol 2018 01 15;141(1):311-321.e10. Epub 2017 Jun 15.

Division of Rheumatology, Allergy and Immunology, Virginia Commonwealth University, Richmond, Va. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2017.02.048DOI Listing
January 2018

Conditioning neoadjuvant therapies for improved immunotherapy of cancer.

Biochem Pharmacol 2017 12 10;145:12-17. Epub 2017 Aug 10.

Massey Cancer Center, USA; Department of Microbiology & Immunology, Virginia Commonwealth University School of Medicine, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2017.08.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681417PMC
December 2017

Tumor Dormancy and Relapse: From a Natural Byproduct of Evolution to a Disease State.

Authors:
Masoud H Manjili

Cancer Res 2017 05;77(10):2564-2569

Department of Microbiology & Immunology, VCU School of Medicine, Massey Cancer Center, Richmond, Virginia.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-54
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-17-0068DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459601PMC
May 2017

Coordinated Upregulation of Mitochondrial Biogenesis and Autophagy in Breast Cancer Cells: The Role of Dynamin Related Protein-1 and Implication for Breast Cancer Treatment.

Oxid Med Cell Longev 2016 26;2016:4085727. Epub 2016 Sep 26.

Department of Human Nutrition, Foods, and Exercise, Fralin Life Science Institute, College of Agriculture and Life Sciences, Virginia Tech, Blacksburg, VA 24061, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2016/4085727DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056295PMC
March 2017

Role of Epigenetic Modification and Immunomodulation in a Murine Prostate Cancer Model.

Prostate 2017 03 8;77(4):361-373. Epub 2016 Nov 8.

Division of Urology, Department of Surgery, Virginia Commonwealth University Medical Center, Richmond, Virginia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23275DOI Listing
March 2017

Low-Dose Mixture Hypothesis of Carcinogenesis Workshop: Scientific Underpinnings and Research Recommendations.

Environ Health Perspect 2017 02 12;125(2):163-169. Epub 2016 Aug 12.

National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1289/EHP411DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289915PMC
February 2017

Role of Tregs in Cancer Dormancy or Recurrence.

Immunol Invest 2016 Nov 7;45(8):759-766. Epub 2016 Sep 7.

a Department of Microbiology and Immunology , Virginia Commonwealth University School of Medicine , Richmond , VA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/08820139.2016.1194428DOI Listing
November 2016

Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells.

J Leukoc Biol 2016 09 29;100(3):625-35. Epub 2016 Feb 29.

Department of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA; Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.5A1215-580RDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982610PMC
September 2016

DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer.

Cancer Immunol Immunother 2016 09 14;65(9):1061-73. Epub 2016 Jul 14.

Department of Surgery, Virginia Commonwealth University, Richmond, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-016-1868-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996686PMC
September 2016

On the organization of human T-cell receptor loci: log-periodic distribution of T-cell receptor gene segments.

J R Soc Interface 2016 Jan;13(114):20150911

Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA, USA.

View Article

Download full-text PDF

Source
http://rsif.royalsocietypublishing.org/lookup/doi/10.1098/rs
Publisher Site
http://dx.doi.org/10.1098/rsif.2015.0911DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759796PMC
January 2016

Etiology of GVHD: alloreactivity or impaired cellular adaptation?

Immunol Invest 2014 ;43(8):851-7

Department of Microbiology & Immunology, Virginia Commonwealth University School of Medicine , Massey Cancer Center, Richmond, VA , USA .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/08820139.2014.953636DOI Listing
July 2015

Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.

Authors:
William H Goodson Leroy Lowe David O Carpenter Michael Gilbertson Abdul Manaf Ali Adela Lopez de Cerain Salsamendi Ahmed Lasfar Amancio Carnero Amaya Azqueta Amedeo Amedei Amelia K Charles Andrew R Collins Andrew Ward Anna C Salzberg Annamaria Colacci Ann-Karin Olsen Arthur Berg Barry J Barclay Binhua P Zhou Carmen Blanco-Aparicio Carolyn J Baglole Chenfang Dong Chiara Mondello Chia-Wen Hsu Christian C Naus Clement Yedjou Colleen S Curran Dale W Laird Daniel C Koch Danielle J Carlin Dean W Felsher Debasish Roy Dustin G Brown Edward Ratovitski Elizabeth P Ryan Emanuela Corsini Emilio Rojas Eun-Yi Moon Ezio Laconi Fabio Marongiu Fahd Al-Mulla Ferdinando Chiaradonna Firouz Darroudi Francis L Martin Frederik J Van Schooten Gary S Goldberg Gerard Wagemaker Gladys N Nangami Gloria M Calaf Graeme Williams Gregory T Wolf Gudrun Koppen Gunnar Brunborg H Kim Lyerly Harini Krishnan Hasiah Ab Hamid Hemad Yasaei Hideko Sone Hiroshi Kondoh Hosni K Salem Hsue-Yin Hsu Hyun Ho Park Igor Koturbash Isabelle R Miousse A Ivana Scovassi James E Klaunig Jan Vondráček Jayadev Raju Jesse Roman John Pierce Wise Jonathan R Whitfield Jordan Woodrick Joseph A Christopher Josiah Ochieng Juan Fernando Martinez-Leal Judith Weisz Julia Kravchenko Jun Sun Kalan R Prudhomme Kannan Badri Narayanan Karine A Cohen-Solal Kim Moorwood Laetitia Gonzalez Laura Soucek Le Jian Leandro S D'Abronzo Liang-Tzung Lin Lin Li Linda Gulliver Lisa J McCawley Lorenzo Memeo Louis Vermeulen Luc Leyns Luoping Zhang Mahara Valverde Mahin Khatami Maria Fiammetta Romano Marion Chapellier Marc A Williams Mark Wade Masoud H Manjili Matilde E Lleonart Menghang Xia Michael J Gonzalez Michalis V Karamouzis Micheline Kirsch-Volders Monica Vaccari Nancy B Kuemmerle Neetu Singh Nichola Cruickshanks Nicole Kleinstreuer Nik van Larebeke Nuzhat Ahmed Olugbemiga Ogunkua P K Krishnakumar Pankaj Vadgama Paola A Marignani Paramita M Ghosh Patricia Ostrosky-Wegman Patricia A Thompson Paul Dent Petr Heneberg Philippa Darbre Po Sing Leung Pratima Nangia-Makker Qiang Shawn Cheng R Brooks Robey Rabeah Al-Temaimi Rabindra Roy Rafaela Andrade-Vieira Ranjeet K Sinha Rekha Mehta Renza Vento Riccardo Di Fiore Richard Ponce-Cusi Rita Dornetshuber-Fleiss Rita Nahta Robert C Castellino Roberta Palorini Roslida Abd Hamid Sabine A S Langie Sakina E Eltom Samira A Brooks Sandra Ryeom Sandra S Wise Sarah N Bay Shelley A Harris Silvana Papagerakis Simona Romano Sofia Pavanello Staffan Eriksson Stefano Forte Stephanie C Casey Sudjit Luanpitpong Tae-Jin Lee Takemi Otsuki Tao Chen Thierry Massfelder Thomas Sanderson Tiziana Guarnieri Tove Hultman Valérian Dormoy Valerie Odero-Marah Venkata Sabbisetti Veronique Maguer-Satta W Kimryn Rathmell Wilhelm Engström William K Decker William H Bisson Yon Rojanasakul Yunus Luqmani Zhenbang Chen Zhiwei Hu

Carcinogenesis 2015 Jun;36 Suppl 1:S254-96

Department of Surgery, The Ohio State University College of Medicine, The James Comprehensive Cancer Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://carcin.oxfordjournals.org/content/36/Suppl_1/S254.ful
Web Search
http://carcin.oxfordjournals.org/content/36/Suppl_1/S254.ful
Web Search
http://www.ilcambiamento.it/files/carcinogenesi.pdf
Web Search
http://www.carcin.oxfordjournals.org/lookup/doi/10.1093/carc
Publisher Site
http://dx.doi.org/10.1093/carcin/bgv039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480130PMC
June 2015

Prospects in cancer immunotherapy: treating advanced stage disease or preventing tumor recurrence?

Discov Med 2015 Jun;19(107):427-31

Department of Microbiology and Immunology and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
June 2015

The inherent premise of immunotherapy for cancer dormancy.

Authors:
Masoud H Manjili

Cancer Res 2014 Dec 19;74(23):6745-9. Epub 2014 Nov 19.

Department of Microbiology and Immunology, Virginia Commonwealth University, Massey Cancer Center, Richmond, Virginia.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/early/2014/11/19/0
Web Search
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-14-2440DOI Listing
December 2014

The adaptation model of immunity.

Authors:
Masoud H Manjili

Immunotherapy 2014 ;6(1):59-70

Department of Microbiology & Immunology, Virginia Commonwealth University, Massey Cancer Center, Box 980035, 401 College Street, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.13.157DOI Listing
August 2014

Adoptive cellular therapy of cancer: exploring innate and adaptive cellular crosstalk to improve anti-tumor efficacy.

Future Oncol 2014 Aug;10(10):1779-94

Department of Microbiology & Immunology, Virginia Commonwealth University, Massey Cancer Center, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.14.97DOI Listing
August 2014

IFN-γ Rα is a key determinant of CD8+ T cell-mediated tumor elimination or tumor escape and relapse in FVB mouse.

PLoS One 2013 6;8(12):e82544. Epub 2013 Dec 6.

Department of Microbiology & Immunology, Virginia Commonwealth University, Massey Cancer Center, Richmond, Virginia, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0082544PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855782PMC
July 2014

Evolution of Our Understanding of Myeloid Regulatory Cells: From MDSCs to Mregs.

Front Immunol 2014 2;5:303. Epub 2014 Jul 2.

Roswell Park Cancer Institute , Buffalo, NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2014.00303DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078244PMC
July 2014

Therapeutic cancer vaccines: past, present, and future.

Adv Cancer Res 2013 ;119:421-75

Department of Human and Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-12-407190-2.00007-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721379PMC
February 2014

Multi-therapeutic potential of autoantibodies induced by immune complexes trapped on follicular dendritic cells.

Hum Vaccin Immunother 2013 Nov 8;9(11):2434-44. Epub 2013 Jul 8.

Centre for Experimental Medicine and Rheumatology; William Harvey Research Institute; Barts and the London School of Medicine and Dentistry; Queen Mary University of London; London, UK.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981854PMC
http://dx.doi.org/10.4161/hv.25596DOI Listing
November 2013

Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells.

Breast Cancer Res Treat 2013 Nov 25;142(1):45-57. Epub 2013 Oct 25.

Department of Microbiology and Immunology, Virginia Commonwealth University, Massey Cancer Center, Box 980035, 401 College Street, Richmond, VA, 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2733-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844228PMC
November 2013

HLA-DR expression on myeloid cells is a potential prognostic factor in patients with high-risk neuroblastoma.

Oncoimmunology 2013 Oct 10;2(10):e26616. Epub 2013 Oct 10.

Department of Microbiology and Immunology; Virginia Commonwealth University; Massey Cancer Center; Richmond, VA USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.4161/onci.26616
Publisher Site
http://dx.doi.org/10.4161/onci.26616DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857328PMC
October 2013

Immunotherapy of cancer: reprogramming tumor-immune crosstalk.

Clin Dev Immunol 2012 11;2012:760965. Epub 2012 Oct 11.

Department of Microbiology & Immunology, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/jir/2012/760965/
Publisher Site
http://dx.doi.org/10.1155/2012/760965DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477552PMC
May 2013

Fractal organization of the human T cell repertoire in health and after stem cell transplantation.

Biol Blood Marrow Transplant 2013 Mar 11;19(3):366-77. Epub 2013 Jan 11.

Bone Marrow Transplant Program, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.12.004DOI Listing
March 2013

Phenotypic plasticity of MDSC in cancers.

Authors:
Masoud H Manjili

Immunol Invest 2012 ;41(6-7):711-21

Department of Microbiology & Immunology, Virginia Commonwealth University, Massey Cancer Center, Richmond, Virginia 232989, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/08820139.2012.673670DOI Listing
February 2013

Adaptive immune responses associated with breast cancer relapse.

Arch Immunol Ther Exp (Warsz) 2012 Oct 22;60(5):345-50. Epub 2012 Aug 22.

Department of Microbiology and Immunology, Massey Cancer Center, Virginia Commonwealth University, 401 College Street, Box 980035, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00005-012-0185-yDOI Listing
October 2012

Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity.

J Immunol 2012 Jul 15;189(2):511-5. Epub 2012 Jun 15.

Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1200647DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392490PMC
July 2012

Signatures of tumor-immune interactions as biomarkers for breast cancer prognosis.

Future Oncol 2012 Jun;8(6):703-11

Department of Microbiology & Immunology, Massey Cancer Center, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.12.57DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634870PMC
June 2012

Suppression of antigen-specific CD4+ T cell activation by SRA/CD204 through reducing the immunostimulatory capability of antigen-presenting cell.

J Mol Med (Berl) 2012 Apr 15;90(4):413-26. Epub 2011 Nov 15.

Department of Human & Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00109-011-0828-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288685PMC
April 2012

CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.

Hum Pathol 2012 Mar 10;43(3):364-73. Epub 2011 Aug 10.

Department of Pathology, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2011.05.005DOI Listing
March 2012

Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systems.

Oncoimmunology 2012 Mar;1(2):201-204

Department of Microbiology and Immunology; Virginia Commonwealth University Massey Cancer Center; Richmond, VA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.1.2.18113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377002PMC
March 2012

A signature of immune function genes associated with recurrence-free survival in breast cancer patients.

Breast Cancer Res Treat 2012 Feb 11;131(3):871-80. Epub 2011 Apr 11.

Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine and Center for Human Immunology, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1470-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431022PMC
February 2012

An immunologic portrait of cancer.

J Transl Med 2011 Aug 29;9:146. Epub 2011 Aug 29.

Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://translational-medicine.biomedcentral.com/articles/10.
Publisher Site
http://dx.doi.org/10.1186/1479-5876-9-146DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175185PMC
August 2011

Revisiting cancer immunoediting by understanding cancer immune complexity.

Authors:
Masoud H Manjili

J Pathol 2011 May;224(1):5-9

Department of Microbiology and Immunology, Virginia Commonwealth University, Massey Cancer Center, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.2865DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092128PMC
May 2011

CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancer.

Breast Cancer Res Treat 2011 Apr 18;126(2):385-94. Epub 2010 May 18.

Department of Microbiology & Immunology, Virginia Commonwealth University Massey Cancer Center, Box 980035, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-0942-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086038PMC
April 2011

Adoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens.

Cancer Immunol Immunother 2011 Mar 19;60(3):349-60. Epub 2010 Nov 19.

Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-010-0939-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042529PMC
March 2011

Ex vivo expansion of tumor-reactive T cells by means of bryostatin 1/ionomycin and the common gamma chain cytokines formulation.

J Vis Exp 2011 Jan 14(47). Epub 2011 Jan 14.

Department of Microbiology & Immunology, Virginia Commonwealth University-Massey Cancer Center, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/2381DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182644PMC
January 2011

GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.

Breast Cancer Res Treat 2010 Aug 8;123(1):39-49. Epub 2009 Nov 8.

Department of Microbiology & Immunology, Virginia Commonwealth University School of Medicine, Massey Cancer Center, Box 980035, 401 College St, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-009-0622-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095485PMC
August 2010

IL-7 + IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo.

Breast Cancer Res Treat 2010 Jul 14;122(2):359-69. Epub 2009 Oct 14.

Department of Physiology and Biophysics, Virginia Commonwealth University's Medical College of Virginia, Richmond, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-009-0573-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033304PMC
July 2010

Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function.

J Transl Med 2009 Oct 22;7:89. Epub 2009 Oct 22.

Department of Microbiology & Immunology, Virginia Commonwealth University Massey Cancer Center, Richmond, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-7-89DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770477PMC
October 2009

Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice.

Int Immunopharmacol 2009 Jul 29;9(7-8):900-9. Epub 2009 Mar 29.

Department of Physiology and Biophysics, Virginia Commonwealth University's Medical College of Virginia, Richmond, Virginia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.intimp.2009.03.015DOI Listing
July 2009

Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis.

Breast Cancer Res Treat 2009 Apr 20;114(3):423-31. Epub 2008 Apr 20.

Department of Microbiology and Immunology, VCU School of Medicine, Massey Cancer Center, 401 College Street, Box 980035, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-008-0024-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2649692PMC
April 2009

Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design.

Cancer Immunol Immunother 2008 Sep 16;57(9):1391-8. Epub 2008 Feb 16.

Department of Microbiology and Immunology, VCU School of Medicine, Massey Cancer Center, 401 College Street, Box 980035, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-008-0475-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2465763PMC
September 2008

Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.

Int J Cancer 2008 Sep;123(6):1376-84

Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.23667DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827153PMC
September 2008

Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors.

Cancer Res 2008 Apr;68(7):2436-46

Department of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Massey Cancer Center, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-6822DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2478745PMC
April 2008

Tumor immunoediting and immunosculpting pathways to cancer progression.

Semin Cancer Biol 2007 Aug 26;17(4):275-87. Epub 2007 Jun 26.

Department of Immunology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, United States.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S1044579X0700034
Publisher Site
http://dx.doi.org/10.1016/j.semcancer.2007.06.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2742305PMC
August 2007

Heat shock proteins and scavenger receptors: role in adaptive immune responses.

Immunol Invest 2005 ;34(3):325-42

Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1081/imm-200064505DOI Listing
April 2007

HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses.

Eur J Immunol 2007 Mar;37(3):675-85

Department of Microbiology & Immunology , VCU School of Medicine, Massey Cancer Center, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.200636639DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732067PMC
March 2007

Come forth 1E10 anti-idiotype vaccine: delivering the promise to immunotherapy of small cell lung cancer.

Authors:
Masoud H Manjili

Cancer Biol Ther 2007 Feb 20;6(2):151-2. Epub 2007 Feb 20.

Department of Microbiology and Immunology, Massey Cancer Center, VCU School of Medicine, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.6.2.4027DOI Listing
February 2007

Heat shock proteins as vaccine adjuvants in infections and cancer.

Drug Discov Today 2006 Jun;11(11-12):534-40

Department of Medicine, Immunology, Cellular Stress Biology, and Urologic Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drudis.2006.04.016DOI Listing
June 2006

Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals".

Breast Cancer Res Treat 2006 Apr 7;96(3):233-41. Epub 2005 Oct 7.

Department of Microbiology and Immunology, Virginia Commonwealth University, Massey Cancer Center, Richmond, VA, 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-005-9044-4DOI Listing
April 2006

Immunoadjuvant chaperone, GRP170, induces 'danger signals' upon interaction with dendritic cells.

Immunol Cell Biol 2006 Apr;84(2):203-8

Department of Microbiology and Immunology, Virginia Commonwealth University, Massey Cancer Centre, Richmond, Virginia 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1711.2006.01418.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094687PMC
April 2006

Erratum to: Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals".

Breast Cancer Res Treat 2006 Apr 16;96(3):243. Epub 2006 Mar 16.

Microbiology & Immunology, Virginia Commonwealth University, Massey Cancer Center, 401 N. College Street, 1-128, 980037, Richmond, VA, 23298-0037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-006-9163-6DOI Listing
April 2006

Heat shock proteins HSP70 and GP96: structural insights.

Cancer Immunol Immunother 2006 Mar 20;55(3):339-46. Epub 2005 Jul 20.

Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-005-0020-yDOI Listing
March 2006

Chaperoning function of stress protein grp170, a member of the hsp70 superfamily, is responsible for its immunoadjuvant activity.

Cancer Res 2006 Jan;66(2):1161-8

Department of Cell Stress Biology, Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-2609DOI Listing
January 2006

HSP110 induces "danger signals" upon interaction with antigen presenting cells and mouse mammary carcinoma.

Immunobiology 2005 ;210(5):295-303

Department of Microbiology & Immunology, Virginia Commonwealth University, Massey Cancer Center, Box 980037, Richmond, VA 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imbio.2005.04.002DOI Listing
October 2005

Cancer immunotherapy and heat-shock proteins: promises and challenges.

Expert Opin Biol Ther 2004 Mar;4(3):363-73

Department of Cellular Stress Biology, Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.4.3.363DOI Listing
March 2004

Development of cancer vaccines using autologous and recombinant high molecular weight stress proteins.

Methods 2004 Jan;32(1):13-20

Department of Molecular and Cellular Biophysics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1046-2023(03)00181-6DOI Listing
January 2004

HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice.

J Immunol 2003 Oct;171(8):4054-61

Department of Molecular and Cellular Biophysics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.171.8.4054DOI Listing
October 2003

Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100.

Cancer Res 2003 May;63(10):2553-60

Department of Molecular and Cellular Biophysics, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.

View Article

Download full-text PDF

Source
May 2003

Hsp110 over-expression increases the immunogenicity of the murine CT26 colon tumor.

Cancer Immunol Immunother 2002 Aug 13;51(6):311-9. Epub 2002 Jun 13.

Department of Molecular and Cellular Biophysics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-002-0287-1DOI Listing
August 2002

Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110.

Cancer Res 2002 Mar;62(6):1737-42

Department of Molecular and Cellular Biophysics, Roswell Park Cancer Institute, Buffalo New York 14263, USA.

View Article

Download full-text PDF

Source
March 2002

Immunotherapy of cancer using heat shock proteins.

Front Biosci 2002 Jan 1;7:d43-52. Epub 2002 Jan 1.

Department of Molecular and Cellular Biophysics, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/manjiliDOI Listing
January 2002